7 Mindsets Acquires BASE Education
18 janv. 2023 09h30 HE
|
7 Mindsets
ROSWELL, Ga., Jan. 18, 2023 (GLOBE NEWSWIRE) -- 7 Mindsets, the leader in PreK-12 mindsets-based learning and well-being solutions, today announced the acquisition of BASE Education, a student...
Indegene expands Europe presence with new center in Germany to enable life sciences companies be future ready
10 janv. 2023 07h30 HE
|
Indegene Inc
FRANKFURT, Germany and PRINCETON, N.J. and BANGALORE, India, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the launch of a new...
Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction
09 janv. 2023 08h00 HE
|
Imbria Pharmaceuticals Inc.
BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced...
Gravity Diagnostics Announces New Director of Compliance
21 déc. 2022 09h04 HE
|
Gravity Diagnostics
Covington, Kentucky, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Gravity Diagnostics, a CAP-accredited, CLIA-certified laboratory licensed in all 50 states, has officially welcomed Erica Adams as their...
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
16 nov. 2022 07h30 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial
16 nov. 2022 07h00 HE
|
Monopar Therapeutics Inc.
WILMETTE, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to...
CORRECTION -- Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
06 nov. 2022 20h20 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Nov. 06, 2022 (GLOBE NEWSWIRE) -- Please note the link in the second paragraph has been updated from the original release issued under the same headline earlier today by...
Late-breaking Data Demonstrate AHA/ACC Guideline-directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing
06 nov. 2022 19h00 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Nov. 06, 2022 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results that show evaluating patients with...
PharmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA
02 nov. 2022 09h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its pre-IND data meeting package to the US Food and Drug...
Compass Therapeutics Announces Clinical Collaboration with Merck to Evaluate CTX-471 in Combination with KEYTRUDA® (pembrolizumab)
11 oct. 2022 08h00 HE
|
Compass Therapeutics
BOSTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer,...